The Rare Brain Disorders Nexus aims to accelerate the development of novel therapies for a spectrum of uncommon brain diseases.

Materials from ancient rocks could reveal conditions in the early solar system that shaped the early Earth and other planets.

The promoter editing system could be used to fine-tune gene therapy or to more efficiently reprogram cells for therapeutic use.

The Institute’s pooled investments returned 14.8 percent last year; endowment stands at $27.4 billion.

Receiving the Robert A. Muh award, the technologist and author heralded a bright future for AI, breakthroughs in longevity, and more.

The associate professor aims to help the department continue to be a worldwide leader in education, biological sciences, and fundamental research.

Speakers at MIT’s Aging Brain Initiative symposium described how immune system factors during aging contribute to Alzheimer’s, Parkinson’s and other conditions. The field is leveraging that knowledge to develop new therapies.

The MIT–MBZUAI Collaborative Research Program will unite faculty and students from both institutions to advance AI and accelerate its use in pressing scientific and societal challenges.

MIT physicist seeks to use award to study magnetoelectric multiferroics that could lead to energy-efficient storage devices.

Proposed system would combine two kinds of plants, creating greater efficiency and lowering costs while curbing climate-changing emissions.